Please complete the CAPTCHA to continue
@ubs.com
✓
3 phones found area 914
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Edward Painter is listed as Chairman and Chief Operating Officer at A2A Pharmaceuticals Inc. at A2A Pharmaceuticals Inc., based in New York City Metropolitan Area, United States. AeroLeads shows a work email signal at ubs.com, phone signal with area code 914, and a matched LinkedIn profile for Edward Painter.
Edward Painter previously worked as Founder, Chairman and COO at A2A Pharmaceuticals Inc. and Managing Member at Shomer Capital Llc. Edward Painter holds Mba, Finance from Gies College Of Business - University Of Illinois Urbana-Champaign.
This section adds company-level context without repeating Edward Painter's masked contact details.
AeroLeads found 1 current-domain work email signal for Edward Painter. Compare company email patterns before reaching out.
Including A2A Pharmaceuticals Inc., I founded 3 companies. Biomea Fusion is a spin-off of A2A focused on Leukemia, multiple solid tumors and diabetes. With the help of A2As proprietary computational new drug design engine, we will be advancing another program into the clinic for oncology in the next 6 months. My experience helping companies form business plans and raise funds in the past 25 years has proved invaluable.
Listed skills include Financial Services, Investor Relations, Asset Allocation, Venture Capital, and 14 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
A2A Pharmaceutical's core pipeline consists of new drug candidates focused on triple negative breast, ovarian and other cancers.
Financial Advisory Services focused on the Biotechnology Industry, Leveraging breakthrough computational chemistry to develop new drug candidates for Oncology and Infectious Diseases
A2A Pharmaceutical's pipeline consists of new drug candidates focused on mixed-lineage leukemia (MLL) and YAP/TEAD solid tumor mechanisms of action. The ADMET properties and potency statistics in the AO-001 and AO-002 programs are dramatically better than alternatives. The infectious disease research at A2A is focused on the LpxC and AroK targets for gram-negative bacteria infections.
Evaluation of business and financing opportunities. Investor and investment bank and relationship management.
Zurich, Ch
Relationship management focused on Biotechnology
Institutional Equity Sales
Corporate bond research
Quick answers generated from the profile data available on this page.
Edward Painter works for A2A Pharmaceuticals Inc..
Edward Painter is listed as Chairman and Chief Operating Officer at A2A Pharmaceuticals Inc. at A2A Pharmaceuticals Inc..
AeroLeads has found 1 work email signal at @ubs.com for Edward Painter at A2A Pharmaceuticals Inc..
AeroLeads has found 3 phone signal(s) with area code 914 for Edward Painter at A2A Pharmaceuticals Inc..
Edward Painter is based in New York City Metropolitan Area, United States while working with A2A Pharmaceuticals Inc..
Edward Painter has worked for A2A Pharmaceuticals Inc., Shomer Capital Llc, A2A Pharmaceuticals, Startup Pharmaceutical Company, and Ubs Investment Bank.
You can use AeroLeads to view verified contact signals for Edward Painter at A2A Pharmaceuticals Inc., including work email, phone, and LinkedIn data when available.
Edward Painter holds Mba, Finance from Gies College Of Business - University Of Illinois Urbana-Champaign.
Edward Painter is listed with skills including Financial Services, Investor Relations, Asset Allocation, Venture Capital, Management, Due Diligence, Mergers And Acquisitions, and Emerging Markets.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts